Micron Technology Crosses 1 Trillion Market Cap as AIDriven Memory Shortage Fuels 19 Stock Surge
Traders Bet on IonQ Micron Anduril as Potential Next US Government Equity Stakes
The Changing Economics of the Office Lunch From Luxury to Workplace Burden
Freedom Broker Lifts Price Target for Bank of America After Strong Q1 Performance
Foresight Ventures Backs PopDEX With 30M to Boost TraderFocused Perpetual DEXs
Mortgage Rates Decline Further on May 27 2026 Continuing Recent Downward Trend
TrustCo Bank Corp NY TRST Q1 2026 Earnings Reported EPS of 091 Stock Edges Lower
BNR Q3 2022 Earnings Narrower Loss Surprises as Revenue Remains Undisclosed
Akebia Therapeutics Inc AKBA Q1 2026 Earnings EPS Misses Estimates Slightly Stock Unchanged
TAL Q1 2026 Earnings Massive EPS Beat Amidst Revenue Uncertainty
Air Lease Corporation AL Q4 2025 Earnings Strong EPS Beat Driven by Portfolio Management and Lease Rate Momentum
ZBIO Q1 2026 Earnings NarrowerThanExpected Loss Amid PreRevenue Stage
Advantage Solutions ADV Faces Minor Pullback Amid Sector Headwinds
KTH Preferred Stock Shows Modest Decline Remains RangeBound Near Support
NioCorp Developments NB Inched Higher Amid Steady Trading Momentum
Spotify SPOT Dips 24 as Selling Pressure Intensifies Support Test Ahead
X Financial XYF Surges 10 Key Levels to Watch After Strong Move
Taiwan Chip Stocks Rally as Nvidias 150B Spending Plans Boost Demand Outlook
CCB Q1 2026 Earnings EPS Falls 261 Below Estimates
Ames National Corporation ATLO Edges Higher in Quiet Trading Consolidating Near Support
CRMT Q1 2026 Earnings Massive EPS Miss as Losses Widen Beyond Expectations
CLOV Q1 2026 Earnings EPS Surges Past Estimates Driving Stock Higher
CISS Q3 2025 Earnings Losses Widen as Stock Declines 512
IMO Q1 2026 Earnings EPS Misses Estimates as Earnings Decline 1955 Below Consensus
UAMY Q1 2026 Earnings EPS Falls Far Short of Estimates as Revenue Remains Unreported
RKDA Q3 2025 Earnings Massive EPS Surprise Driven by NonOperating Gains Revenue Still Absent
Skye Bioscience Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges